| Dr James A Mcguire, DO | |
|
2000 Ogden Ave, Aurora, IL 60504-7222 | |
| (630) 978-4860 | |
| Not Available |
| Full Name | Dr James A Mcguire |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 39 Years |
| Location | 2000 Ogden Ave, Aurora, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235142464 | NPI | - | NPPES |
| 036075554 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | 036075554 (Illinois) | Secondary |
| 207L00000X | Anesthesiology | 036075554 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Copley Memorial Hospital | Aurora, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Guardian Anesthesia Associates, S.c | 3870494347 | 31 |
News Archive
The crunch of helmets as players tangle for a loose football, the swoosh of the net as an outside jumper is made and the crack of the bat as a guaranteed double sails into right center field are awesome sounds to sports fans but for dentists, they're reminders that a player is just one misstep away from a dental injury.
A new type of therapy aimed at reversing the gene-silencing that promotes cancer-cell growth has shown promising results in a small clinical trial conducted by researchers at the Johns Hopkins Kimmel Cancer Center.
Neoadjuvant, or pre-surgical, combination treatment with the immune checkpoint inhibitors tremelimumab (anti-CTLA-4) and durvalumab (anti-PD-1) was well-tolerated and showed early signs of activity in certain patients with localized bladder cancer who do not have standard treatment options available, according to a Phase I clinical trial conducted by The University of Texas MD Anderson Cancer Center.
Patients could be saved millions of trips to their GP under a new scheme that has the potential to revolutionise the system of prescribing medicines.
› Verified 6 days ago
| Entity Name | Guardian Anesthesia Associates, S.c |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326097221 PECOS PAC ID: 3870494347 Enrollment ID: O20040116000932 |
News Archive
The crunch of helmets as players tangle for a loose football, the swoosh of the net as an outside jumper is made and the crack of the bat as a guaranteed double sails into right center field are awesome sounds to sports fans but for dentists, they're reminders that a player is just one misstep away from a dental injury.
A new type of therapy aimed at reversing the gene-silencing that promotes cancer-cell growth has shown promising results in a small clinical trial conducted by researchers at the Johns Hopkins Kimmel Cancer Center.
Neoadjuvant, or pre-surgical, combination treatment with the immune checkpoint inhibitors tremelimumab (anti-CTLA-4) and durvalumab (anti-PD-1) was well-tolerated and showed early signs of activity in certain patients with localized bladder cancer who do not have standard treatment options available, according to a Phase I clinical trial conducted by The University of Texas MD Anderson Cancer Center.
Patients could be saved millions of trips to their GP under a new scheme that has the potential to revolutionise the system of prescribing medicines.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James A Mcguire, DO 185 Penny Ave, East Dundee, IL 60118-1454 Ph: (847) 836-7015 | Dr James A Mcguire, DO 2000 Ogden Ave, Aurora, IL 60504-7222 Ph: (630) 978-4860 |
News Archive
The crunch of helmets as players tangle for a loose football, the swoosh of the net as an outside jumper is made and the crack of the bat as a guaranteed double sails into right center field are awesome sounds to sports fans but for dentists, they're reminders that a player is just one misstep away from a dental injury.
A new type of therapy aimed at reversing the gene-silencing that promotes cancer-cell growth has shown promising results in a small clinical trial conducted by researchers at the Johns Hopkins Kimmel Cancer Center.
Neoadjuvant, or pre-surgical, combination treatment with the immune checkpoint inhibitors tremelimumab (anti-CTLA-4) and durvalumab (anti-PD-1) was well-tolerated and showed early signs of activity in certain patients with localized bladder cancer who do not have standard treatment options available, according to a Phase I clinical trial conducted by The University of Texas MD Anderson Cancer Center.
Patients could be saved millions of trips to their GP under a new scheme that has the potential to revolutionise the system of prescribing medicines.
› Verified 6 days ago
Dr. Jose S Sison, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2000 Ogden Ave, Rush Copley Medical Center, Aurora, IL 60504 Phone: 630-978-6200 | |
Vi Dang, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: Provena Mercy Medical Center, 1325 N. Highland Avenue, Aurora, IL 60506 Phone: 630-859-2222 | |
Dr. David A. Estacio, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2000 Ogden Ave, Aurora, IL 60504 Phone: 630-978-4860 | |
Dr. Nagarajan R. Iyer, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2000 Ogden Ave, Aurora, IL 60504 Phone: 630-978-4860 | |
Dr. David Wenzel, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2000 Ogden Ave, Aurora, IL 60504 Phone: 630-978-4860 | |
Anya Raskin, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: Provena Mercy Medical Center, 1325 N. Highland Avenue, Aurora, IL 60506 Phone: 630-859-2222 | |
Taratip Thupvong, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2000 Ogden Ave, Aurora, IL 60504 Phone: 630-978-6200 |